Navigation Links
Fizzy Logic For A Perfect Drink: Courtesy Boffins

London: Champagne drinkers world over have one more reason to raise a toast- a formula for that perfect frothy glass. Here’s the news on how you // can pep-up your spirits and relish the fizz. Dr Steve Smith, Principal Lecturer in Wine Studies at Coventry University, and author of the formula for Marks & Spencer, says it is worthwhile to recall the laws while popping open a champagne bottle. According to smith, P = T/4.5 + 1, where P is pressure and T is temperature-when the temperature is at 5 to 7 degrees the pressure will be 2 to 2.5 atmospheres, a third less than normal. Therefore, uncorking a bottle of champagne at a lower temperature is not only a safer option but also a tastier option! The Mirror, quoted Smith, saying, “There are four reasons why we should open it at the optimum temperature: When the temperature is lower the pressure will be lower, making it safer. Secondly, champagne tastes better when chilled as acidity is emphasized. Thirdly, there’s more fizz and more enjoyment. Lastly, the colder the champagne, the slower the bubbles are released which means you can enjoy them for longer.”
'"/>




Page: 1

Related medicine news :

1. Complete Ban on Fizzy Drinks in Schools
2. The Logic Behind The Spread Of SARS
3. You Can Be Emotional And Logical
4. Perfect babies boon or a bane?
5. Roller-Coasters Isn’t The Perfect Place For Cardiac Patients To Be
6. New Garlic Product Mimics Garlic to Perfection
7. Dare Not Mercy kill – Courtesy: The Care Not Killing Grou
8. Single Women with Baby Cravings Can Actually Cradle their Own, Courtesy NHS
9. Micro vascular Disease Enabled with a Superior Test, Courtesy: Women’s Heart Progra
10. Better Ice Creams And Artificial Snow, Courtesy Bacteria
11. Better Healthcare for 100 Villages - Courtesy Indian American Physicians
Post Your Comments:
(Date:5/12/2008)...gulatory Authority Over Tobacco, WASHINGTON, Ma...est,Hispanic faith-based organization in the count...he Family Smoking Prevention and Tobacco Control,A...y over tobacco products., "We encourage Congres...R. 1108 has broad bi-partisan support and could ge...
(Date:5/11/2008)...Biotechnology and Biological Sciences Research Cou...o investigate important aspects of human ageing. ...niversity, Dr Lynne Cox and Dr Robert Saunders hav...s can now be used to study the effects ageing has ...l Aging Cell, the researchers demonstrate the valu...
(Date:5/11/2008)...swire-USNewswire/ -- The situation for children,co...ren have been separated,from their families, many ...camps, and some are drinking water from ponds cove...., The information is contained in a new situatio...mar. It details the most urgent needs of women,and...
(Date:5/11/2008)... waiting, bracing and, sometimes, surgery, , ... spines are naturally curved and flexible so that ...some people, the natural curve of the spine doesn,...r "C" shape. , This condition is known as scoli...ording to the National Scoliosis Foundation. While...
Breaking Medicine News(10 mins):Health News:Human aging gene found in flies 2Health News:UNICEF REPORT: Desperate Conditions for Children in Camps Without Clean Water as Cyclone Aftermath Worsens 2Health News:UNICEF REPORT: Desperate Conditions for Children in Camps Without Clean Water as Cyclone Aftermath Worsens 3Health News:UNICEF REPORT: Desperate Conditions for Children in Camps Without Clean Water as Cyclone Aftermath Worsens 4Health News:Scoliosis: An Unnatural Curve 2Health News:Scoliosis: An Unnatural Curve 3
...g to new study some light was thrown on the vision...y the condition. The study focuses on the risk of ...least 2 percent of the population is born with amb...y countries routinely screen for lazy eye. The goa...
...g to new research finds heart patients who are giv...er risk of returning to the hospital for chest pai..., England //say that the reduced risk was not rel... playing a role in heart disease. The effect was s...
...ers in a new survey observe that many people are s...sk factors. Oral and throat cancers account for ab...n be investigated by a dentist and early diagnosis...ey by dental experts at New York University shows,...
...long period of study, it shows little difference i...east surgery. The radical mastectomy - total remov...- is far less often done nowadays as a treatment f... for a simple mastectomy or even a lumpectomy, whi...
Other Medicine News:
(Date:5/8/2008)...TON, May 8 /- The Cancer Research All...on,s top cancer centers, is asking,303 million Ame...ting $1 to,cancer research efforts this Mother,s D...e "Infinite Power of One(TM)" has two key goals:,t...to their own hands by,joining together to exercise...
(Date:5/8/2008)...PA, Fla., May 8 /- Alpharma...ical company, today announced results from,clinica... sulfate,extended-release with sequestered naltrex...y relevant features addressing abuse liability,alo...e Phase I and II,studies, presented at the 27th An...
(Date:5/8/2008)... HAVEN, Conn., May 8 /- VIO...ounced the start of an investigator-sponsored,Phas... Cloretazine(R),(VNP40101M) in combination with cy...ated acute myelogenous leukemia (AML) and high-ris...ing conducted under the,direction of Ellen K. Ritc...
(Date:5/8/2008)...orial Sloan-Kettering Cancer Center Investigators ...ve Ovarian Cancer Patients -, BRISBANE, Calif., M...nounced the expansion of Phase 2 clinical trial pr...ancer. This is the third major clinical trial,of B...s, expanding on,on-going trials in breast and brai...
Breaking Medicine Technology:World Renowned Cancer Centers Implore Americans to Donate $1 to Make Change and Accelerate Cancer Research 2World Renowned Cancer Centers Implore Americans to Donate $1 to Make Change and Accelerate Cancer Research 3World Renowned Cancer Centers Implore Americans to Donate $1 to Make Change and Accelerate Cancer Research 4World Renowned Cancer Centers Implore Americans to Donate $1 to Make Change and Accelerate Cancer Research 5Alpharma Presents Data Addressing Abuse Liability Features, Safety and Efficacy on ALO-01 (EMBEDA(TM)) (morphine sulfate extended-release with sequestered naltrexone hydrochloride) at the American Pain Society Annual Scientific Session 2Alpharma Presents Data Addressing Abuse Liability Features, Safety and Efficacy on ALO-01 (EMBEDA(TM)) (morphine sulfate extended-release with sequestered naltrexone hydrochloride) at the American Pain Society Annual Scientific Session 3Alpharma Presents Data Addressing Abuse Liability Features, Safety and Efficacy on ALO-01 (EMBEDA(TM)) (morphine sulfate extended-release with sequestered naltrexone hydrochloride) at the American Pain Society Annual Scientific Session 4Alpharma Presents Data Addressing Abuse Liability Features, Safety and Efficacy on ALO-01 (EMBEDA(TM)) (morphine sulfate extended-release with sequestered naltrexone hydrochloride) at the American Pain Society Annual Scientific Session 5Alpharma Presents Data Addressing Abuse Liability Features, Safety and Efficacy on ALO-01 (EMBEDA(TM)) (morphine sulfate extended-release with sequestered naltrexone hydrochloride) at the American Pain Society Annual Scientific Session 6Alpharma Presents Data Addressing Abuse Liability Features, Safety and Efficacy on ALO-01 (EMBEDA(TM)) (morphine sulfate extended-release with sequestered naltrexone hydrochloride) at the American Pain Society Annual Scientific Session 7Vion Pharmaceuticals Announces Initiation of Clinical Trial of Cloretazine(R) (VNP40101M) in Combination with Cytarabine 2Vion Pharmaceuticals Announces Initiation of Clinical Trial of Cloretazine(R) (VNP40101M) in Combination with Cytarabine 3BiPar Sciences Expands Phase 2 Clinical Trials of BSI-201, a Novel DNA Repair Inhibitor, in Ovarian Cancer 2Link between chronic kidney disease and oxygen deprived tissue 8460 1Link between chronic kidney disease and oxygen deprived tissue 8460 2Dolphin therapy a dangerous fad Emory researchers warn 1644 1Dolphin therapy a dangerous fad Emory researchers warn 1644 2Dolphin therapy a dangerous fad Emory researchers warn 1644 3A research of the UGR shows the genetic predisposition to develop alcohol abuse 1640 1A research of the UGR shows the genetic predisposition to develop alcohol abuse 1640 2BioMarin Re Acquires Rights to Kuvan in Canada From Merck Serono 8454 1BioMarin Re Acquires Rights to Kuvan in Canada From Merck Serono 8454 2BioMarin Re Acquires Rights to Kuvan in Canada From Merck Serono 8454 3BioMarin Re Acquires Rights to Kuvan in Canada From Merck Serono 8454 4
...ent Preclinical Data From Study of,Oral Formulatio...SBURG, Md., April 10, 2007 (PRIME,NEWSWIRE) -- Inf...mmune, Inc. (Nasdaq:MEDI) today announced that dat...n of IPI-504 in non-small,cell lung cancer (NSCLC)...of the American Association for Cancer Research (A...
...rated and Potentially Suited for Once,Daily Admini...ire-FirstCall/ --,Pharmacopeia , an innovator in t...le therapeutics, today announced positive results,...0, the company,s,lead internal product candidate f...ropathy. Data from the single ascending dose (SAD)...
Other Medicine Technology:Infinity and MedImmune to Present Preclinical Data From Study of,Oral Formulation of IPI-504 At AACR 2Infinity and MedImmune to Present Preclinical Data From Study of,Oral Formulation of IPI-504 At AACR 3Infinity and MedImmune to Present Preclinical Data From Study of,Oral Formulation of IPI-504 At AACR 4Pharmacopeia Announces Positive Results from Initial DARA Clinical,Trial 2Pharmacopeia Announces Positive Results from Initial DARA Clinical,Trial 3Pharmacopeia Announces Positive Results from Initial DARA Clinical,Trial 4Pharmacopeia Announces Positive Results from Initial DARA Clinical,Trial 5
Calcitonin EIA Bone and Mineral Metabolism 021-SDX017
...-GBM was developed to detect the presence of antib...e information is clinically useful in diagnosing G...3 chain antibody formation along with glomerulonep...stic parameters. Since there are several other con...
Anti-PR3 EIA Auto-Immune Markers 013-PR3-48 Proteinase
Circulating Immune Complexes from patient serum or plasma, standards and controls are incubated with human C1q absorbed onto microtiter wells. After a washing step, an alkaline phosphatase labeled c
Medicine Products: